As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.
7 Analysts have issued a Tempest Therapeutics Inc forecast:
7 Analysts have issued a Tempest Therapeutics Inc forecast:
Jun '25 |
+/-
%
|
||
Revenue | - - |
-
|
|
Gross Profit | - - |
-
|
|
EBITDA | -43 -43 |
38%
38%
|
EBIT (Operating Income) EBIT | -43 -43 |
37%
37%
|
Net Profit | -43 -43 |
36%
36%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Tempest Therapeutics, Inc.is a clinical-stage biotechnology company. It develops small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. The company is headquartered in South San Francisco, CA.
Head office | United States |
CEO | Stephen Brady |
Employees | 24 |
Founded | 2011 |
Website | www.tempesttx.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.